Self-Reported Allergic Adverse Events Following Inactivated SARS-CoV-2 Vaccine (TURKOVAC™) among General and High-Risk Population

TURKOVAC™ is a whole-virion inactivated COVID-19 vaccine which was developed and granted emergency use and conditional marketing authorization in December 2021 in Türkiye. The objective of this study is to assess the distribution and the severity of allergic adverse events following the administrati...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ateş Kara, Aslihan Coskun, Fehminaz Temel, Pervin Özelci, Selmur Topal, İhsan Ates
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-02-01
Edice:	Vaccines
Témata:	COVID-19 vaccine allergy adverse events
On-line přístup:	https://www.mdpi.com/2076-393X/11/2/437
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!